检索结果-南通市图书馆

Reliability and validity of Persian version of Medical Outcome Study-HIV health survey in Iranian people living with HIV

引用

Journal of Traditional Chinese Medicine 2017年第5期37卷 695-701页

作者： Marzieh Alamolhoda Peyman Jafari Seyyed Mohammad Taghi Ayatollahi parvin afsar kazerooni Department of Biostatistics School of Medicine Shiraz University of Medical Sciences Shiraz 71348-45794 Iran Behavioral Disease Counseling Center Shiraz HIV AIDS Research Center Shiraz University of Medical Sciences Shiraz 71348-14336 Iran

OBJECTIVE: To evaluate the psychometric properties of the Persian version of the medical outcome study human immunodeficiency virus(MOS-HIV)health survey among people living with HIV or acquired immune deficiency syndrome(HIV/AIDS) in Iran is our main goal in this ***: The MOS-HIV questionnaire was translated into Persian using backward translation and the Persian version was filled by 100 HIV infected patients. Reliability of the questionnaire was estimated using Cronbach's alpha coefficient for the total questionnaire and for each dimension. Convergent, discriminant and construct validity were performed. Comparisons were performed between the subscales of the questionnaire in Iran and some other countries with ***: The overall Cronbach's alpha in this study was 0.90 and the range of this coefficient was from 0.71 to 0.86 across the subscales with two exceptions, general health perception and role functioning, which were at 0.65 and 0.61. Convergent and discriminant validity were excellent in all domains. The two factor confirmatory factor analysis showed a good fit based on standardized estimates of factor loading, incremental and absolute fit ***: The Persian version of the MOS-HIV had good reliability and validity in measuring health related quality of life in people living with HIV in Iran. Furthermore, quality of life for HIV infected patients was very low in comparing with the people in some other countries.

关键词： Acquired immunodeficiency syndrome HIV Quality of life Cross-sectional studies Health surveys

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Survival rate and the determinants of progression from HIV to AIDS and from AIDS to the death in Iran: 1987 to 2016

引用

Asian Pacific Journal of Tropical Medicine 2019年第2期12卷 72-78页

作者： Mohammad Mirzaei Maryam Farhadian Jalal Poorolajal parvin afsar kazerooni Katayoun Tayeri Younes Mohammadi Department of Epidemiology School of Public Health Hamadan University of Medical Sciences Research Center for Health Sciences Department of Biostatistics School of Public Health Hamadan University of Medical Sciences Modeling of Noncommunicable Diseases Research Center Department of Epidemiology School of Public Health Hamadan University of Medical Sciences HIV/AIDS Research Center Shiraz University of Medical Sciences Iranian Research Center of HIV&AIDS Tehran University of Medical Sciences Social Determinants of Health Research Center School of Public Health Hamadan University of Medical Sciences

Objective: To examine the prognostic factors of progression from HIV to AIDS and AIDS to the death in people living with HIV/AIDS in ***: In this registry-based retrospective cohort study, we recruited 28 873 HIV-infected people from 158 Behavioral Diseases Counseling Centers of *** outcomes of interest included survival rates from HIV diagnosis to AIDS and from AIDS to the *** used Kaplan-Meier and Cox regression model to investigate survival rate and factors affecting on survival controlling effect of confounding ***: The one, three, five, and ten-year survival rate from HIV to AIDS were 85%, 73%, 61% and 32%, and for AIDS to death were 90%, 81%, 74% and 55%, *** Cox regression analysis indicated that the risk of progression from AIDS phase toward death in individuals with CD4 less than 200/mm^3, infected with tuberculosis(TB) and not treated by antiretroviral therapy(ART) was 2.17(95% CI: 1.62-2.90), 1.49(95% CI: 1.01-2.20) and 4.88(95% CI: 3.42-6.96) times higher *** risk of progression to AIDS in patients with baseline CD4 less than 200/mm^3 was 2.32(95% CI: 2.14, 2.51) times higher than patients with CD4 > 200/mm^3(P=0.001).On the other hand, tuberculosis increases the risk of death by 49.0%(P=0.04).The hazard ratio of death in patients who did not receive ART was 4.88(95% CI: 3.42, 6.96) times higher than patients who received ART(P<0.001).Conclusion: The early detection of HIV, the screening and treatment of TB and receiving the ART improve the survival of HIV/AIDS patients significantly, and prevent the transmission of HIV to other people.

关键词： HIV/AIDS Prognostic factor Survival time Tuberculosis Cohort study

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：